Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rooney

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|February 5, 2025
Tenofovir Disoproxil Fumarate/Emtricitabine Prophylaxis Has No Effect on Bone Mineral Density and Bone Mineral Content in African Breastfeeding Women Receiving Pre-Exposure Prophylaxis for HIVGaysheen Kistan, Motshedisi Sebitloane, Carl Lombard, et al.
Journal of the International AIDS Society|November 11, 2024
In-utero exposure to tenofovir-containing pre-exposure prophylaxis and bone mineral content in HIV-unexposed infants in South AfricaKerusha Reddy, Kimesh L Naidoo, Carl Lombard, et al.
Annals of Internal Medicine|February 15, 1993
Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trialJ F Rooney, S E Straus, M L Mannix, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Efficacious Anti-Cancer Drugs Targeting Nicotinamide <i>N</i>-Methyltransferase (NNMT) in Cultured Human Oral Squamous Cell Carcinoma (OSCC)Brian Maloney, Martyna Kubisztal, Ziqian Ge, et al.
The Journal of Infectious Diseases|September 1, 1992
UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovirJ F Rooney, S E Straus, M L Mannix, et al.
AIDS and Behavior|June 8, 2025
Stakeholder Perspectives on a Community-Based Peer-Led Biomedical HIV Prevention Intervention for Women Who Engage in Sex Work in Southwestern Uganda: Results from a Qualitative StudyCecilia Akatukwasa, Jennifer Velloza, Milliam Korukiiko, et al.
British Journal of Pharmacology|January 1, 1987
Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390S Barasi, M M Ben-Sreti, A L Clatworthy, et al.
The Journal of Antimicrobial Chemotherapy|March 23, 2007
No change in calculated creatinine clearance after tenofovir initiation among Thai patientsAngele Gayet-Ageron, Jintanat Ananworanich, Thidarat Jupimai, et al.
The Journal of Infectious Diseases|July 29, 2016
Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus InfectionIvana Massud, James Mitchell, Darius Babusis, et al.
Science Translational Medicine|December 14, 2011
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmissionKristine B Patterson, Heather A Prince, Eric Kraft, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
Journal of Acquired Immune Deficiency Syndromes (1999)|February 5, 2025
Tenofovir Disoproxil Fumarate/Emtricitabine Prophylaxis Has No Effect on Bone Mineral Density and Bone Mineral Content in African Breastfeeding Women Receiving Pre-Exposure Prophylaxis for HIVGaysheen Kistan, Motshedisi Sebitloane, Carl Lombard, et al.
Journal of the International AIDS Society|November 11, 2024
In-utero exposure to tenofovir-containing pre-exposure prophylaxis and bone mineral content in HIV-unexposed infants in South AfricaKerusha Reddy, Kimesh L Naidoo, Carl Lombard, et al.
Annals of Internal Medicine|February 15, 1993
Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trialJ F Rooney, S E Straus, M L Mannix, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Efficacious Anti-Cancer Drugs Targeting Nicotinamide <i>N</i>-Methyltransferase (NNMT) in Cultured Human Oral Squamous Cell Carcinoma (OSCC)Brian Maloney, Martyna Kubisztal, Ziqian Ge, et al.
The Journal of Infectious Diseases|September 1, 1992
UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovirJ F Rooney, S E Straus, M L Mannix, et al.
AIDS and Behavior|June 8, 2025
Stakeholder Perspectives on a Community-Based Peer-Led Biomedical HIV Prevention Intervention for Women Who Engage in Sex Work in Southwestern Uganda: Results from a Qualitative StudyCecilia Akatukwasa, Jennifer Velloza, Milliam Korukiiko, et al.
British Journal of Pharmacology|January 1, 1987
Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390S Barasi, M M Ben-Sreti, A L Clatworthy, et al.
The Journal of Antimicrobial Chemotherapy|March 23, 2007
No change in calculated creatinine clearance after tenofovir initiation among Thai patientsAngele Gayet-Ageron, Jintanat Ananworanich, Thidarat Jupimai, et al.
The Journal of Infectious Diseases|July 29, 2016
Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus InfectionIvana Massud, James Mitchell, Darius Babusis, et al.
Science Translational Medicine|December 14, 2011
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmissionKristine B Patterson, Heather A Prince, Eric Kraft, et al.
Pageof 17